Semin Liver Dis 2000; Volume 20(Number 03): 365-372
DOI: 10.1055/s-2000-9384
Copyright © 2000 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Genetic Defects in Hepatocanalicular Transport

RICHARD. THOMPSON1 , PETER. L.M. JANSEN2
  • 1Department of Child Health Guy's, King's and St. Thomas' School of Medicine, King's College Hospital, London, United Kingdom
  • 2Division of Gastroenterology and Hepatology, University Hospital Groningen, Groningen, The Netherlands
Further Information

Publication History

Publication Date:
31 December 2000 (online)

ABSTRACT

Bile is made as the result of active transport of its constituents into the biliary space. Most of this transport occurs across the canalicular membrane, with a further contribution from cholangiocytes. Water moves passively into bile. The major substrates that are transported out of hepatocytes are bile acids, phospholipids, cholesterol, and bilirubin. With the exception of cholesterol, each of these major substrates is now recognized to have its own transport mechanism. In the case of bile acids and phospholipids, the transporters appear to be specific, though the bilirubin transporter is multispecific. Isolated autosomal recessive defects in all three of these transporters have now been identified and have helped to confirm the physiologic role of these proteins. In addition, a secondary defect in bile acid transport has been identified that appears to be due to an abnormality in plasma membrane aminophospholipid distribution.

REFERENCES

  • 1 Alonso E M, Snover D C, Montag A. Histologic pathology of the liver in progressive familial intrahepatic cholestasis.  J Pediatr Gastroenterol Nutr . 1994;  18 128-133
  • 2 Whitington P F, Freese D K, Alonso E M. Clinical and biochemical findings in progressive familial intrahepatic cholestasis.  J Pediatr Gastroenterol Nutr . 1994;  18 134-141
  • 3 Jacquemin E, Dumont M, Bernard O. Evidence for defective primary bile acid secretion in children with progressive familial intrahepatic cholestasis (Byler disease).  Eur J Pediatr . 1994;  153 424-428
  • 4 Clayton R J, Iber F L, Ruebner B H. Byler disease. Fatal familial intrahepatic cholestasis in an Amish kindred .  Am J Dis Child . 1969;  117 112-124
  • 5 Strautnieks S S, Bull L N, Knisely A S. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis.  Nat Genet . 1998;  20 233-238
  • 6 Jansen P L, Strautnieks S S, Jacquemin E. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis.  Gastroenterology . 1999;  117 1370-1379
  • 7 Childs S, Yeh R L, Georges E. Identification of a sister gene to P-glycoprotein.  Cancer Res . 1995;  55 2029-2034
  • 8 Gerloff T, Stieger B, Hagenbuch B. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver.  J Biol Chem . 1998;  273 10046-10050
  • 9 Childs S, Yeh R L, Hui D. Taxol resistance mediated by transfection of the liver-specific sister gene of P-glycoprotein.  Cancer Res . 1998;  58 4160-4167
  • 10 Strautnieks S S, Kagalwalla A F, Tanner M S. Identification of a locus for progressive familial intrahepatic cholestasis PFIC2 on chromosome 2q24.  Am J Hum Genet . 1997;  61 630-633
  • 11 Carlton V E, Knisely A S, Freimer N B. Mapping of a locus for progressive familial intrahepatic cholestasis (Byler disease) to 18q21-q22, the benign recurrent intrahepatic cholestasis region.  Hum Mol Genet . 1995;  4 1049-1053
  • 12 Houwen R H, Baharloo S, Blankenship K. Genome screening by searching for shared segments: Mapping a gene for benign recurrent intrahepatic cholestasis.  Nat Genet . 1994;  8 380-386
  • 13 Bull L N, van Eijk M J, Pawlikowska L. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis .  Nat Genet . 1998;  18 219-224
  • 14 Bull L N, Carlton V E, Stricker N L. Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): Evidence for heterogeneity .  Hepatology . 1997;  26 155-164
  • 15 Tang X, Halleck M S, Schlegel R A. A subfamily of P-type ATPases with aminophospholipid transporting activity .  Science . 1996;  272 1495-1497
  • 16 Mutero A, Bull L N, Pawlikowska L. Cloning and tissue distribution of the rat homologue of the human gene involved in familial intrahepatic cholestasis type 1.  Hepatology . 1998;  28 530A
  • 17 Ujhazy P, Ortiz D F, Misra S. ATP-dependent aminophospholipid translocase activity in rat canalicular membrane vesicles and its relationship to FIC1.  Hepatology . 1999;  30 462A
  • 18 Lazaridis K N, Pham L, Tietz P. Rat cholangiocytes absorb bile acids at their apical domain via the ileal sodium-dependent bile acid transporter.  J Clin Invest . 1997;  100 2714-2721
  • 19 Deleuze J F, Jacquemin E, Dubuisson C. Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis.  Hepatology . 1996;  23 904-908
  • 20 Smit J J, Schinkel A H, Oude Elferink R P. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease.  Cell . 1993;  75 451-462
  • 21 de V ree, Jacquemin E, Sturm E. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis .  Proc Natl Acad Sci USA . 1998;  95 282-287
  • 22 Dixon P H, Weerasekera N, Linton K J. Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: Evidence for a defect in protein trafficking.  Hum Mol Genet . 2000;  9 1209-1217
  • 23 Jacquemin E, Cresteil D, Manouvrier S. Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy.  Lancet . 1999;  353 210-211
  • 24 Jansen P L, Peters W H, Lamers W H. Hereditary chronic conjugated hyperbilirubinemia in mutant rats caused by defective hepatic anion transport.  Hepatology . 1985;  5 573-579
  • 25 Paulusma C C, Kool M, Bosma P J. A mutation in the human canalicular multispecific organ anion transporter gene causes the Dubin-Johnson syndrome.  Hepatology . 1997;  25 1539-1542
  • 26 König J, Rost D, Cui Y. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane.  Hepatology . 1999;  29 1156-1163
  • 27 Tsujii H, König J, Rost D. Exon-intron organization of the human multidrug-resistance protein 2 (MRP2) gene mutated in Dubin-Johnson syndrome.  Gastroenterology . 1999;  117 653-660
  • 28 Wada M, Toh S, Taniguchi K. Mutations in the canilicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II/Dubin-Johnson syndrome.  Hum Mol Genet . 1998;  7 203-207
    >